IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis

Osteoporosis International

Volumn 25, Issue 2, 2014, Pages 783-786

  Molnar I ^a   Bohaty, I ^b   Somogyine Vari E ^a  

^a Immunoendocrinology and Osteoporosis Centre EndoMed   (Hungary)

^b Regional Transfusion Centre of Debrecen Hungary   (Hungary)

Author keywords

Bone mineral density; Interleukin 17; Osteoporosis; Postmenopause; SRANK ligand

Indexed keywords

CYTOKINE; ESTROGEN; INTERLEUKIN 17; LIGAND; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; IL17A PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR; TNFRSF11B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; VERY ELDERLY; BLOOD; LUMBAR VERTEBRA; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMENOPAUSE;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; INTERLEUKIN-17; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PREMENOPAUSE; RANK LIGAND;

EID: 84899082279     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2548-6     Document Type: Article

References (17)

1. Horowitz MC (1993) Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260:626-627
2. Riggs BL (2000) The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106:1203-1204
3. Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pachrco E, Van G, Bolon B, Feige U, Zack D, Kostenuik P (2009) RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison anti-TNFα or anti-IL-1 therapies. Arthritis & Therapy. doi:10.1186/ ar2879
4. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T (2002) The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 4:281-289 (Pubitemid 34947141)
5. Miossec P, Korm T, Kuchroo VK (2009) Interleukin17 and type 17 helper T cells. N Engl J Med 361:888-898
6. Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, Molès JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180:7423-7430
7. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim HJ, Saito S, Nishikawa T, Takahashi N, Togari A, TomatsuT ST, Kamatani N (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes. Arthritis & Rheumatism 44:1003-1012
8. Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3: 168-177 (Pubitemid 32303433)
9. Geusens P, Lems WF (2011) Osteoimmunology and osteoporosis. Arthritis Res 13:242-257
10. Gaffen SL (2004) Biology of recently discovered cytokines: interleukin-17 - a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther 6:240-247
11. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673-2682 (Pubitemid 44833343)
12. Ley K, Smith E, Stark MA (2006) IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 34:229-242 (Pubitemid 44195938)
13. Braun T, Zwerina J (2011) Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther 13:235
14. Das S, Crockett JC (2013) Osteoporosis - a current view of pharmacological prevention and treatment. Drug Des Devel Ther 7:435-448
15. Teitelbaum SL (2004) Postmenopausal osteoporosis, T cells, and immune dysfunction. PNAS 101:16711-16712
16. Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D (2012) Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. Plos One 7:e44552-e44564
17. Molnár I, Bohaty I, Somogyiné-Vári É (2014) A high prevalence of increased IL-17A serum levels in postmenopausal estrogen deficiency. Menopause. doi:10.1097/GME.0000000000000125